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Background
During the production of any recombinant proteins, an
evaluation of the product quality is crucial. Proteolytic
events may occur during the process and could influ-
ence the product quality. Indeed, proteolysis is an
unpredictable process and relatively little is know
regarding the proteolytic enzymes produced and
released by mammalian cells. In fact, proteases originat-
ing from the host cell line cannot be avoided in cell cul-
ture. Due to regulatory and safety prospects, the
addition of serum, fetuin or albumin that usually limit
protease activities, is not desirable. Thus, in serum-free
cultures of mammalian cells, control of protease activity
constitutes a major challenge.
In the present work, the presence of proteases and
their effect on quality of IFN-g produced by a recombi-
nant CHO cell line cultivated in a stirred-tank bioreac-
tor were studied. Whereas the quality of IFN-g
remained constant during the CHO cell cultures per-
formed in BDM medium, IFN-g proteolysis was
observed when cultures were carried out in RPMI med-
ium with serum [1,2].
Materials and methods
IFN-g producing CHO cell lines (CHO 320: dhfr
+, a2,6
ST
-) were grown in RPMI supplemented with 5% serum
and in BDM medium [3]. Whereas RPMI is a classical
medium containing serum, BDM is a chemically defined
medium without any proteins or serum addition, but
supplemented with 0.1% pluronic F-68, 750 µM ethano-
lamine and 500 µM iron citrate.
Batch cultures were performed in stirred-tank bioreac-
tor (Inceltech, SGI). Dissolved oxygen concentration was
set at 50% of air saturation. Agitation rate used was 50
rpm; pH and temperature were set at 7.2 and 37°C
respectively.
Glycosylation macroheterogeneity of IFN-g was char-
acterized by Western Blot (Amersham Biosciences).
Gelatinase and caseinase activities were performed
using zymography. Cell-free culture supernatants were
concentrated 2-fold on a 10-kDa cutoff filter. Then, the
concentrated samples were instantly mixed 3:1 with
nonreducing electrophoresis sample buffer (4.8 mL
H2O ;1 . 2m LT r i s - H C l0 . 5Mp H6 . 8 ;2m LS D S1 0 % ;1
mL glycerol; 0.5 mL bromophenol blue) and loaded on
t h ez y m o g r a mg e l s .T h eS D S - P A G Eg e l s( 1 0 %a c r y l a -
mide) contained either 0.05% caseine or 0.1% gelatin.
The gels were run at 25 mA for 1h. To remove SDS,
the gels were soaked twice for 30 min in 2% Triton X-
100 on a shaker, then washed in distilled H2O followed
by an 24h incubation in developing buffer (0.5 M Tris,
pH 7.4, 1 µM Zn
2+ and 5 mM Ca
2+). Inhibitor supple-
mentations were also performed using EDTA
a,P M S F
b
and Complete inhibitor Cocktail
c. Visualization of pro-
tease activity was carried out by incubation for around
3h in a Coomassie blue solution.
aEDTA (ethylenediaminetetraacetic acid) = inhibitor of
metalloprotease activities
bComplete, Mini, EDTA-free (Roche) = serine and
cysteine proteases inhibitor cocktail
cPMSF (phenylmethylsulfonyl fluoride) = inhibitor of
serine protease activities
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CHO cell cultures producing human recombinant IFN-g
were cultivated in stirred-tank bioreactor in both RPMI
supplemented with 5% serum and BDM media. In both
media, three major molecular weight variants (2N, 1N,
0N) were detected during the process with a majority of
IFN-g doubly-glycosylated (2N) whatever the medium
used. However, using the RPMI medium with serum,
IFN-g proteolysis was observed during the whole culture
(Figure 1).
To determine the protease activities during CHO cell
cultures performed in both media, zymogram gels
containing either gelatin or casein were performed.
Among the 5 caseinase activities detected when CHO
cell cultures were performed with serum (Table 1), only
the protease activities present all over the process could
be potentially involved in the IFN-g proteolysis (220, 90
Figure 1 Western blot analysis of excreted IFN-g produced by CHO cells cultivated in various media; RPMI serum, BDM and RPMI serum
supplemented with iron citrate
Table 1 Protease activities detected by zymography
during CHO cell cultures performed in RPMI medium
with serum and BDM medium
Molecular Weight (kDa) RPMI medium with serum BDM medium
Caseinase activities 220, 140, 90, 85 and 40 kDa 90 and 85 kDa
Gelatinase activities 95, 90 and 65 kDa 90 kDa
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Page 2 of 3and 85 kDa). In addition, 2 gelatinase activities were
detected during the whole process (90 and 65 kDa).
When CHO cell cultures were carried out using pro-
tein-free BDM medium, 2 caseinase activities (90 and 85
kDa) and 1 gelatinase activity (90 kDa) were detected.
To determine the type of protease activities present, dif-
ferent inhibitors were used in zymogram gels containing
either casein or gelatin. EDTA inhibited all the gelati-
nase activities, identifying these enzymes as metallopro-
teases, whereas PMSF and Complete inhibitor Cocktail
inhibited all the caseinase activities, classifying these
enzymes as serine proteases (data not shown).
Compositions of both BDM and RPMI with serum
were compared and 3 components which are present in
BDM but completely absent in RPMI were identified.
These 3 components are pluronic F-68 (PF-68), iron
citrate and ethanolamine. Interestingly, addition of iron
citrate in the developing buffer of zymogram gels
allowed to inhibit the metalloprotease activities, most
likely by blocking the Zinc atom in the catalytic domain
(data not shown). CHO cell cultures were then per-
formed in RPMI serum supplemented with iron citrate.
Addition of iron citrate to RPMI serum allowed to mini-
mized IFN-g proteolysis (Figure 1). Furthermore, when
CHO cell cultures were performed in BDM medium
without iron citrate during the first 30 hours of the cul-
ture, IFN-g proteolysis was detected (data not shown).
Therefore, IFN-g proteolysis has at least one cellular ori-
gin and the protease responsible for IFN-g proteolysis is
most likely a metalloprotease (Molecular Weight close
to 90 kDa).
Conclusions
Using zymogram analysis, gelatinase and caseinase activ-
ities in CHO batch cultures performed with or without
serum were detected, and belong most likely to the
metalloprotease and serine protease families. When cul-
tures were carried out in RPMI with serum, a degrada-
tion of recombinant IFN-g was observed, while no IFN-g
proteolysis was detected in culture performed with
BDM medium. Furthermore, our results showed that
despite the medium used (RPMI, BDM, with or without
serum), addition of iron minimized IFN-g proteolysis,
probably due to the inhibition of a 90 kDa metallopro-
tease activity. Thus, we demonstrated that the addition
of iron citrate can be advantageously considered for
industrial processes to prevent the proteolysis of a
recombinant protein, in particular if one or several
metalloproteases are present in the culture.
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